200 related articles for article (PubMed ID: 6131925)
1. Interaction of the mouse thyrotrophin receptor with thyrotrophin binding inhibitor immunoglobulins.
Luttrell BM
J Endocrinol; 1983 Mar; 96(3):481-8. PubMed ID: 6131925
[TBL] [Abstract][Full Text] [Related]
2. Comparison of human and porcine thyroid membranes for radioreceptor assay of bovine thyrotrophin and thyrotrophin-binding inhibiting immunoglobulins.
Humphries H; Dirmikis SM; Munro DS
J Endocrinol; 1982 Jun; 93(3):371-80. PubMed ID: 6123540
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the radioreceptor assay of TSH: the properties of TSH-binding inhibitor immunoglobulins (TBII) in patients with Hashimoto's thyroiditis (author's transl)].
Endo K
Nihon Naibunpi Gakkai Zasshi; 1979 Oct; 55(10):1275-85. PubMed ID: 228999
[TBL] [Abstract][Full Text] [Related]
4. Thyrotrophin binding inhibiting immunoglobulins in Graves' disease before, during and after antithyroid therapy, and its relation to long-acting thyroid stimulator.
Docter R; Bos G; Visser TJ; Hennemann G
Clin Endocrinol (Oxf); 1980 Feb; 12(2):143-53. PubMed ID: 6105023
[TBL] [Abstract][Full Text] [Related]
5. [Studies on the radioreceptor assay of TSH: the properties of TSH-binding inhibitor immunoglobulins (TBII) in patients with Graves' disease (author's transl)].
Endo K
Nihon Naibunpi Gakkai Zasshi; 1979 Oct; 55(10):1261-74. PubMed ID: 228998
[TBL] [Abstract][Full Text] [Related]
6. Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease.
Macchia E; Fenzi GF; Monzani F; Lippi F; Vitti P; Grasso L; Bartalena L; Baschieri L; Pinchera A
Clin Endocrinol (Oxf); 1981 Aug; 15(2):175-82. PubMed ID: 6118213
[TBL] [Abstract][Full Text] [Related]
7. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis.
Endo K; Kasagi K; Konishi J; Ikekubo K; Okuno T; Takeda Y; Mori T; Torizuka K
J Clin Endocrinol Metab; 1978 May; 46(5):734-9. PubMed ID: 45421
[TBL] [Abstract][Full Text] [Related]
8. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.
Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T
J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672
[TBL] [Abstract][Full Text] [Related]
9. Discrepancy between thyroid-stimulating and thyrotropin-binding inhibitory activities of Graves' immunoglobulin Gs assessed in the mouse.
Shishiba Y; Ozawa Y; Ohtsuki N; Shimizu T
J Clin Endocrinol Metab; 1982 Apr; 54(4):858-62. PubMed ID: 6277983
[TBL] [Abstract][Full Text] [Related]
10. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
[TBL] [Abstract][Full Text] [Related]
11. The species specificity of TSH receptor binding antibodies as measured by radioreceptor study.
Strakosch CR; Joyner D; Manley SW; Wall JR
Clin Endocrinol (Oxf); 1982 Aug; 17(2):173-9. PubMed ID: 6127179
[TBL] [Abstract][Full Text] [Related]
12. Measurement of thyroid-stimulating immunoglobulins by incorporation of tritiated-adenine into intact FRTL-5 cells: a viable alternative to radioimmunoassay for the measurement of cAMP.
Leedman PJ; Frauman AG; Colman PG; Michelangeli VP
Clin Endocrinol (Oxf); 1992 Dec; 37(6):493-9. PubMed ID: 1363083
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of serum basal thyrotrophin levels and thyrotrophin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease.
Cho BY; Shong MH; Yi KH; Lee HK; Koh CS; Min HK
Clin Endocrinol (Oxf); 1992 Jun; 36(6):585-90. PubMed ID: 1358483
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.
Morris JC; Hay ID; Nelson RE; Jiang NS
Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572
[TBL] [Abstract][Full Text] [Related]
15. The interaction of thyrotrophin binding inhibiting immunoglobulins with high and low affinity TSH receptors.
Pekonen F; Mäkinen T
Acta Endocrinol Suppl (Copenh); 1983; 251():33-7. PubMed ID: 6132509
[TBL] [Abstract][Full Text] [Related]
16. Detection of TSH-binding inhibitor immunoglobulins by using the triton-solubilized receptor from human thyroid membranes.
Iida Y; Konishi J; Kasagi K; Kuma K; Torizuka K
Endocrinol Jpn; 1982 Apr; 29(2):227-31. PubMed ID: 6127209
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
[TBL] [Abstract][Full Text] [Related]
18. A stable, reproducible radioreceptorassay for thyrotropin binding inhibiting immunoglobulins (TBII).
Bliddal H
Scand J Clin Lab Invest; 1981 Sep; 41(5):441-9. PubMed ID: 6118939
[TBL] [Abstract][Full Text] [Related]
19. Radioreceptor assay of anti-TSH receptor antibody activity: comparison of assays using unextracted serum and immunoglobulin fractions, and standardization of expression of activities.
Tamaki H; Amino N; Watanabe Y; Aozasa M; Hayashi H; Tachi J; Miyai K
J Clin Lab Immunol; 1986 May; 20(1):1-6. PubMed ID: 3016274
[TBL] [Abstract][Full Text] [Related]
20. The assay of Graves' immunoglobulins: a comparison of different methods.
Hardisty CA; Kendall-Taylor P; Atkinson S; Humphries H; Munro DS
Clin Endocrinol (Oxf); 1983 Jun; 18(6):637-44. PubMed ID: 6136348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
